Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,520.36
(
0.02%
)
US TECH 100
29,131.60
(
-0.27%
)
Dow Jones
50,644.28
(
0.36%
)
Brent Oil
93.70
(
1.36%
)
Bitcoin
74,335.66
(
-0.73%
)
News Focus
News Focus
Post# of 30991
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

bhp1rtp

Send PM Follow Ignore
Followers 7
Posts 317
Boards Moderated 0
Alias Born 12/08/2013

bhp1rtp

Re: leifsmith post# 21995

Friday, 01/30/2015 3:49:41 PM

Friday, January 30, 2015 3:49:41 PM

Post# of 30991
Yes I agree with your statement

"However, since the therapeutic effect to be measured is reduction of inflammation, and not the consequence of inflammation in any specific disease, it seems that more trials, targeting specific diseases, will be required before a product can be marketed.

The length of such trials, in many cases, might be short."



Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today